Advertisement

Topics

Symyx Technologies, Inc. Company Profile

07:52 EDT 19th September 2017 | BioPortfolio

Symyx Technologies, Inc. is dedicated to helping customers maximize the effectiveness and success of their research & development programs. Symyx develops and applies high-throughput research technologies and research software for customers in the chemical, energy, pharmaceutical, electronics and other industries. Symyx performs research for customers using proprietary technologies to discover new and innovative materials, sells automated high-throughput instrumentation and licenses software for use in customers’ own laboratories, and licenses discovered materials, sensors and intellectual property. Symyx has the largest portfolio of patents in the field of high-throughput materials discovery. Three of Symyx's discovered materials have been commercialized, including a catalyst to produce Dow's VERSIFY™ Plastomers and Elastomers, a needle storage phosphor used in Agfa's DX-S Computed Radiography system, and a polymer used in electronic applications by JSR. In addition, Symyx has a pipeline of materials in commercial development. Symyx customers comprise leading organizations, including large strategic alliances with the Dow Chemical Company and ExxonMobil. Symyx Software and Tools are used by many pharmaceutical, biotech, chemical and energy companies.
We apply our technologies to discover innovative materials for high-value industrial applications in a broad range of industries. Our customers include chemical, energy, life science, electronic, consumer goods, and automotive companies. Among our discovered materials — three of which have been commercialized — are catalysts for the manufacture of plastics and chemicals, polymers for a range of consumer and industrial applications, and x-ray storage phosphors used in computed radiography. Our customers include approximately 25 leading companies worldwide, including BP, the Dow Chemical Company, Eli Lilly and Company, ExxonMobil Company, Honda, and Merck & Co., Inc. Two of these customers — ExxonMobil and Dow — have entered into broad-based strategic alliances with us under which we are performing research, developing and transferring Symyx Tools, and licensing software and intellectual property. Dow, ExxonMobil and others have committed over $600 million for strategic partnerships with Symyx.

Location

3100 Central Expressway
Santa Clara
California
95051
United States of America

Contact

Phone: 408-764-2000
Fax: 408-748-0175
Email: support@symyx.com


News Articles [421 Associated News Articles listed on BioPortfolio]

Advanced Enzymes acquires evoxx

The industrial biotechnology company evoxx technologies GmbH has become a part of specialty biotech company Advanced Enzyme Technologies Limited. Both companies announced that they have entered into a...

Partnership agreement signed to combine epigenetics technologies

A partnership agreement has been entered into by Cambridge Epigenetix (CEGX) and NuGEN Technologies to cover the manufacture and integration of technologies for epigenetic research.

Agilent acquires Cobalt, expanding value for pharma and biopharma

Specialist in analytical laboratory technologies, Agilent Technologies, has acquired Cobalt Light Systems, which develops products and technologies for non-invasive, through-barrier chemical analysis ...

DBV Technologies: DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors

Press Release Montrouge, France, June 15, 2017 DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Mar...

AMS Technologies Extends Design Services with Acquisition of Elforlight

Acquisition strengthens company’s competence and expertise for solving the most challenging photonics applications  AMS Technologies, Europe’s leading solution provider and distributo...

Palatin Technologies: Lust auf mehr Lust statt Frust

Weitere Kursgewinne sind vorprogrammiert bei Palatin Technologies (US6960774031). Die Bodenbildung laut Charts im Artikel Palatin Technologies: Kurvenreicher Lustgewinn durch Ausdauer ist tatsächl...

Reviewing Flamel Technologies

Flamel Technologies and Acura Pharmaceuticals are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitabiliy,...

DBV Technologies Annonce les Résultats de son Assemblée Générale Mixte 2017

DBV Technologies — Thursday, June 15th 2017 at 8:30pm UTC Informations Réglementées Montrouge, France, le 15 juin 2017, 22h30 CEST DBV Technologies Annonce les Résultats de son Assemblée Gé...

PubMed Articles [415 Associated PubMed Articles listed on BioPortfolio]

Advanced technologies for the remediation of pesticide-contaminated soils.

The occurrence of pesticides in soil has become a highly significant environmental problem, which has been increased by the vast use of pesticides worldwide and the absence of remediation technologies...

Enhancing the Gaming Experience Using 3D Spatial User Interface Technologies.

Three-dimensional (3D) spatial user interface technologies have the potential to make games more immersive and engaging and thus provide a better user experience. Although technologies such as stereos...

Technologies to Support Community-Dwelling Persons With Dementia: A Position Paper on Issues Regarding Development, Usability, Effectiveness and Cost-Effectiveness, Deployment, and Ethics.

With the expected increase in the numbers of persons with dementia, providing timely, adequate, and affordable care and support is challenging. Assistive and health technologies may be a valuable cont...

3D Metal Printing - Additive Manufacturing Technologies for Frameworks of Implant-Borne Fixed Dental Prosthesis.

An edentulous patient was rehabilitated with maxillary metal-ceramic and mandibular metal-resin implant-supported fixed dental prosthesis (FDP). Metal frameworks of the FDPs were fabricated using 3D a...

Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.

The utility of the levels of amyloid beta (Aβ) peptide and tau in blood for diagnosis, drug development, and assessment of clinical trials for Alzheimer's disease (AD) has not been established. The l...

Clinical Trials [308 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Longitudinal Study of Chronic Wounds Using Novel Wound Measurement Technologies

An open, non-randomised longitudinal study of diabetic foot ulcers receiving standardised treatment, over a 16 week period conducted at out-patient level, utilising novel optical wound mea...

Companies [1220 Associated Companies listed on BioPortfolio]

Symyx Technologies, Inc

Symyx Technologies, Inc. is dedicated to helping customers maximize the effectiveness and success of their research & development programs. Symyx develops and applies high-throughput research technol...

Symyx Technologies

Symyx is pioneering high-speed combinatorial technologies for the discovery of new materials. Our proprietary technologies - including instruments, software and methods - enable us to generate hundred...

Symyx Technologies, Inc.

Symyx Technologies, Inc. is dedicated to helping customers maximize the effectiveness and success of their research & development programs. Symyx develops and applies high-throughput research technol...

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

CA Technologies

CA Technologies (NASDAQ: CA) is an IT management software and solutions company with expertise across all IT environments - from mainframe and distributed, to virtual and cloud. For additional inf...

More Information about "Symyx Technologies, Inc." on BioPortfolio

We have published hundreds of Symyx Technologies, Inc. news stories on BioPortfolio along with dozens of Symyx Technologies, Inc. Clinical Trials and PubMed Articles about Symyx Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Symyx Technologies, Inc. Companies in our database. You can also find out about relevant Symyx Technologies, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record